Campbell & Co Investment Adviser’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-56,402
Closed -$3.54M 1061
2026
Q1
$3.54M Sell
56,402
-20,570
-27% -$1.65M 0.2% 139
2025
Q4
$7.34M Buy
76,972
+59,705
+346% +$5.85M 0.35% 41
2025
Q3
$1.69M Buy
17,267
+14,949
+645% +$1.55M 0.13% 244
2025
Q2
$249K Buy
+2,318
New +$235K 0.02% 1009
2024
Q1
Sell
-8,777
Closed -$507K 1119
2023
Q4
$507K Buy
+8,777
New +$469K 0.05% 702
2023
Q3
Sell
-17,145
Closed -$927K 957
2023
Q2
$927K Buy
17,145
+6,682
+64% +$349K 0.17% 177
2023
Q1
$523K Buy
10,463
+5,366
+105% +$253K 0.1% 403
2022
Q4
$236K Buy
+5,097
New +$221K 0.06% 635
2022
Q2
Sell
-11,050
Closed -$489K 691
2022
Q1
$489K Buy
+11,050
New +$479K 0.13% 286
2019
Q2
Sell
-12,958
Closed -$497K 539
2019
Q1
$497K Buy
+12,958
New +$495K 0.24% 120
2018
Q2
Sell
-10,080
Closed -$275K 385
2018
Q1
$275K Buy
+10,080
New +$274K 0.23% 195
2016
Q4
Sell
-15,217
Closed -$362K 146
2016
Q3
$362K Buy
+15,217
New +$363K 0.97% 31
2014
Q3
Sell
-210,381
Closed -$2.69M 196
2014
Q2
$2.69M Buy
+210,381
New +$2.74M 1.07% 34
2014
Q1
Sell
-108,968
Closed -$1.31M 215
2013
Q4
$1.31M Buy
+108,968
New +$1.29M 0.29% 108

Other funds holding BSX

Campbell & Co Investment Adviser's BSX Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 56,402 shares — an estimated $3.54M sold.

Campbell & Co Investment Adviser first reported a position in BSX in Q4 2013 and held it in 14 quarters. The position peaked at $7.34M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 56,402 Boston Scientific shares in Q2 2026, an estimated $3.54M.
  • Campbell & Co Investment Adviser first reported a position in Boston Scientific in Q4 2013 and held it in 14 quarters.
  • Campbell & Co Investment Adviser's Boston Scientific position peaked at $7.34M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.